Insulin-like Growth Factor-I Receptor (IGF-IR) Translocates to Nucleus and Autoregulates IGF-IR Gene Expression in Breast Cancer Cells
暂无分享,去创建一个
N. Shomron | H. Werner | E. Wertheimer | Liat Edry | M. Pasmanik-Chor | A. Yeheskel | R. Sarfstein | L. Shochat | Naama Warman | S. Maor
[1] S. Leung,et al. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes , 2012, Breast Cancer Research and Treatment.
[2] Adrian V. Lee,et al. Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth , 2012, Breast Cancer Research and Treatment.
[3] Adrian V. Lee,et al. The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells. , 2011, Molecular endocrinology.
[4] O. Larsson,et al. Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9. , 2011, Biochemical and biophysical research communications.
[5] D. Leroith,et al. Elevated circulating IGF-I promotes mammary gland development and proliferation. , 2010, Endocrinology.
[6] L. Sciacca,et al. Insulin and its analogs: actions via insulin and IGF receptors , 2010, Acta Diabetologica.
[7] M. Howarth,et al. Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. , 2010, Cancer research.
[8] Tal Pupko,et al. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids , 2010, Nucleic Acids Res..
[9] H. Werner,et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells , 2010, Cancers.
[10] O. Larsson,et al. SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor , 2010, Science Signaling.
[11] H. Werner,et al. Targeting the IGF1 axis in cancer proliferation , 2009, Expert opinion on therapeutic targets.
[12] M. Pollak,et al. Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.
[13] A. Rowzee,et al. IGF Ligand and Receptor Regulation of Mammary Development , 2008, Journal of Mammary Gland Biology and Neoplasia.
[14] A. Belfiore,et al. IGF and Insulin Receptor Signaling in Breast Cancer , 2008, Journal of Mammary Gland Biology and Neoplasia.
[15] M. Pollak,et al. The Type 1 Insulin-Like Growth Factor Receptor Pathway , 2008, Clinical Cancer Research.
[16] Adrian V. Lee,et al. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] P. Picci,et al. Targeting insulin-like growth factor 1 receptor in sarcomas , 2008, Current opinion in oncology.
[18] R. Yarden,et al. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations. , 2007, Cancer letters.
[19] Burkhard Rost,et al. Prediction of DNA-binding residues from sequence , 2007, ISMB/ECCB.
[20] L. Chodosh,et al. Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation , 2007, Oncogene.
[21] Seungwoo Hwang,et al. DP-Bind: a web server for sequence-based prediction of DNA-binding residues in DNA-binding proteins , 2007, Bioinform..
[22] D. Leroith,et al. The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.
[23] Adrian V. Lee,et al. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. , 2006, The Journal of endocrinology.
[24] H. Werner,et al. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action , 2006, Trends in Endocrinology & Metabolism.
[25] Liangjiang Wang,et al. BindN: a web-based tool for efficient prediction of DNA and RNA binding sites in amino acid sequences , 2006, Nucleic Acids Res..
[26] K. Katoh,et al. MAFFT version 5: improvement in accuracy of multiple sequence alignment , 2005, Nucleic acids research.
[27] Shandar Ahmad,et al. Analysis and prediction of DNA-binding proteins and their binding residues based on composition, sequence and structural information , 2004, Bioinform..
[28] H. Werner,et al. Functional and Physical Interactions between BRCA1 and p53 in Transcriptional Regulation of the IGF-IR Gene , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[29] R. Baserga,et al. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. , 2003, Molecular endocrinology.
[30] H. Werner,et al. WT1-p53 Interactions in Insulin-like Growth Factor-I Receptor Gene Regulation* , 2003, The Journal of Biological Chemistry.
[31] M. Martin,et al. Insulin-like growth factor-I and estrogen interactions in breast cancer. , 2002, The Journal of nutrition.
[32] K. Makino,et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.
[33] C. Osborne,et al. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. , 2001, Cancer research.
[34] B. Katzenellenbogen,et al. Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Role for Akt in Mediating the Estrogenic Functions of Epidermal Growth Factor and Insulin-Like Growth Factor I* , 2000 .
[35] A. Benner,et al. Down‐regulation of insulin‐like growth factor‐I receptor and insulin receptor substrate‐1 expression in advanced human breast cancer , 2000, International journal of cancer.
[36] M. van Eickels,et al. Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway* , 2000, The Journal of Biological Chemistry.
[37] H. Werner,et al. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia , 2000, Cellular and Molecular Life Sciences CMLS.
[38] M. Erdos,et al. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1. , 2000, Molecular genetics and metabolism.
[39] Philip Smith,et al. The localization of the insulin‐like growth factor receptor 1 (IGFR‐1) in benign and malignant breast tissue , 1997, The Journal of pathology.
[40] H. Werner,et al. Differential Regulation of Insulin-like Growth Factor-I (IGF-I) Receptor Gene Expression by IGF-I and Basic Fibroblastic Growth Factor* , 1997, The Journal of Biological Chemistry.
[41] H. Werner,et al. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[42] Daniel Metzger,et al. Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.
[43] V. Sukhatme,et al. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. , 1994, The Journal of biological chemistry.
[44] M. Rubini,et al. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[45] H. Werner,et al. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. , 1992, Molecular endocrinology.
[46] D. Cooke,et al. Analysis of the human type I insulin-like growth factor receptor promoter region. , 1991, Biochemical and biophysical research communications.
[47] D. Baltimore,et al. The “initiator” as a transcription control element , 1989, Cell.
[48] S. Leung,et al. Insulin-like growth factor receptor ( IGF-1 R ) in breast cancer subtypes , 2012 .
[49] H. Werner,et al. The insulin-like growth factor-I receptor as an oncogene. , 2009, Archives of physiology and biochemistry.
[50] H. Werner. The Pathophysiological Significance of IGF-I Receptor Overexpression: New Insights , 2009 .
[51] V. Macaulay,et al. Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer. , 2008, Expert opinion on therapeutic targets.
[52] Michel Schneider,et al. UniProtKB/Swiss-Prot. , 2007, Methods in molecular biology.
[53] J. Bonneterre,et al. Type 1 IGF receptor in human breast diseases , 2005, Breast Cancer Research and Treatment.
[54] Adrian V. Lee,et al. Crosstalk Between the Insulin-Like Growth Factors and Estrogens in Breast Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.
[55] E. Surmacz. Function of the IGF-I Receptor in Breast Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.